PRESS RELEASE published on 12/11/2023 at 12:00, 2 years 9 months ago Wex Pharmaceuticals Inc. Commences Its Quantitative Sensory Testing Clinical Trial Evaluating the Impact of Halneuron(R) on Healthy Volunteers’ Sensory Perceptions
PRESS RELEASE published on 01/03/2023 at 17:20, 3 years 8 months ago Wex Pharmaceuticals Inc. Enrolls the First Patient in The Phase 2b Clinical Trial Evaluating the Efficacy and Safety of Halneuron(R) In the Treatment of Chemotherapy-Induced Neuropathic Pain
Published on 09/16/2026 at 23:45, 8 hours 21 minutes ago Galway Metals Settles Claim by Former Employee with Cash and Share Payments
Published on 09/16/2026 at 21:30, 10 hours 36 minutes ago Torq Completes $1.7 Million Private Placement
Published on 09/16/2026 at 16:55, 15 hours 11 minutes ago CORRECTION FROM SOURCE: SLAM Reports 1.60% Copper Equivalent Over 14.45 Meters in Hole GW26-33; Trenching Gold-Antimony Targets on Moose Lake Project
Published on 09/16/2026 at 15:00, 17 hours 6 minutes ago 2026 Canada's Top 40 Under 40(R) Honourees Announced
Published on 09/16/2026 at 14:00, 18 hours 6 minutes ago Ameriwest Awaits Bornite Core Assay Results and Provides Q3 2026 Corporate Update
Published on 09/17/2026 at 07:15, 51 minutes ago Infracore ergänzt ihr Angebot für die Immobilien des Spitals Wetzikon und verlängert dessen Gültigkeit bis zum 31. Oktober 2026
Published on 09/17/2026 at 07:00, 1 hour 5 minutes ago Helvetia Baloise delivers strong half-year operating results and fast integration progress while maintaining excellent capitalisation
Published on 09/17/2026 at 07:00, 1 hour 5 minutes ago MCH Group continues its progress with a strong first half year result, further strengthening profitability
Published on 09/17/2026 at 07:00, 1 hour 5 minutes ago AEVIS VICTORIA SA: Publication of the Half-Year Report 2026 – Significant improvement in Swiss Medical Network’s profitability – Hospitality segment records encouraging results
Published on 09/17/2026 at 07:00, 1 hour 5 minutes ago MindMaze Therapeutics Announces MindMotion Lite to Expand Home-Based Neurorehabilitation
Published on 09/16/2026 at 17:45, 14 hours 21 minutes ago Report on share repurchases from 9 to 15 September 2026
Published on 09/16/2026 at 07:00, 1 day 1 hour ago bioMérieux Receives IVDR Class D CE Marking for BIOFIRE® Respiratory 2.1 plus Panel and BIOFIRE® FILMARRAY® Pneumonia plus Panel, the first syndromic tests including MERS-CoV to achieve this certification
Published on 09/15/2026 at 18:00, 1 day 14 hours ago Report on the Combined General Meeting of the 10th of September 2026
